Neomycin and Polymyxin B Sulfates (Watson Laboratories, Inc.)


Welcome to the PulseAid listing for the Neomycin and Polymyxin B Sulfates drug offered from Watson Laboratories, Inc.. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Watson Laboratories, Inc.
NON-PROPRIETARY NAME: Neomycin and Polymyxin B Sulfates
SUBSTANCE NAME: NEOMYCIN SULFATE; POLYMYXIN B SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient]
ROUTE: IRRIGATION
DOSAGE FORM: IRRIGANT
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-10-25
END MARKETING DATE: 0000-00-00


Neomycin and Polymyxin B Sulfates HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNeomycin and Polymyxin B Sulfates from Watson Laboratories, Inc.
LABELER NAME: Watson Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 40; 200000(mg/mL; [USP’U]/mL)
START MARKETING DATE: 2010-10-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-2190_fcad3af1-37ba-4f76-982d-713b266803b2
PRODUCT NDC: 0591-2190
APPLICATION NUMBER: ANDA062664

Other NEOMYCIN SULFATE; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Pfizer Laboratories Div Pfizer IncNEOSPORIN G.U.
Watson Laboratories, Inc.Neomycin and Polymyxin B Sulfates
X-GEN Pharmaceuticals, Inc.Neomycin and Polymyxin B Sulfates